Transitional Cell Tumor
📧 Sign up to get email alerts when something new happens for Transitional Cell Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating sequential PD-1/PD-L1 inhibition followed by LENvatinib in transitional cell tumor and hepatoblastoma …